RNA Pol II Inhibitor-Bacteria is under clinical development by Hamlet Pharma and currently in Phase I for Inflammation.
Biologists at Indiana University Bloomington have shown that the surfaces of plant leaves are coated with a diverse array of ...
Biologists at Indiana University Bloomington have shown that the surfaces of plant leaves are coated with a diverse array of ...